 The purpose of this study is to determine whether a commonly prescribed orally inhaled corticosteroid treatment will induce a clinically meaningful elevation in intraocular pressure, when administered to patients with ocular hypertension OHT or open-angle glaucoma OAG. Based on the response to high-dose corticosteroids, this patient group is more likely than the normal population to demonstrate this adverse effect. 